A randomized waiting-list controlled study on the efficacy and cost effectiveness of blended treatment to reduce anxiety in children with Anxiety disorders and possible comorbid ADHD, ASD or mental disability.

Recruiting

Conditions: anxiety disorder
10002861

Registration Number: NL-OMON42739

Lead Sponsor: Karakter, Kinder en Jeugdpsychiatirie

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Not specified

Target Recruitment: 40

Inclusion Criteria

1. Children (boys and girls) aged between 8;0 years and 17;11 years
2. Diagnosed with an anxiety disorder, classified by the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 2000) by a child- and adolescent psychiatrist within Karakter.
3. Optionally diagnosed with one of the below comorbid disorders
a) ADHD
b) ASD
c) Mild intellectual disability or borderline intellectual functioning (504. Access to a PC with internet connection

Exclusion Criteria

1. Children receiving other treatment focused on the anxiety disorder
2. Acute psychoses
3. Children with current suicidal problems
4. Children with severe motor or visual impairment
5. Participation in another clinical trial simultaneously
6. Insufficient motivation to follow the treatment

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameter is the measured difference in reported anxiety level<br /><br>and anxiety diagnosis (ADIS-C, RCADS). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The health care consumption of the child and the parents (TIC-P), excluding the<br /><br>research intervention is the second study parameter. The EQ-5d will be used to<br /><br>look at health outcome as judged by the individual respondents and finally a<br /><br>qualitative interview is conducted to look at the experiences of clients<br /><br>(parents en children) and therapists with the blended intervention. </p><br>